Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2009

View Archived Issues

Novel beta-secretase 1 inhibitors developed by Schering-Plough for AD therapy

Potent dual orexin receptor antagonist SB-649868 shows hypnotic properties in multiple studies

Novartis reports trial results of adjuvanted cell culture-based influenza A(H1N1) vaccine

Autologous immunosuppressive regulatory B cells show promise in autoimmune disease therapy in vivo

DTriP-22 shows potent anti-enterovirus 71 activity by inhibiting NS5B

Andrographolide analogue exhibits significant antibacterial activity

FDA Advisory Committee recommends approval of romidepsin for cutaneous T-cell lymphoma

Takeda presents results from first quarter of 2009, ending June 30

OSI initiates two clinical trials of OSI-906

GSK claims AMPA glutamate receptor ligands for psychotic disorders

FDA grants Cytopia clearance for CYT-387 trials in U.S.

Enanta identifies novel hepatitis C virus NS3 NS4A protease inhibitors

Phase II study suggests telmisartan may reverse epirubicin cardiotoxicity in cancer patients

Sanwa describes thyroid hormone receptor ligands for the treatment of hyperlipidemia

Taiho presents retinoid RARalpha receptor agonists as antitumor agents

Grifols launches anti-hepatitis B immunoglobulin, Niuliva

Endo launches Valstar for bladder cancer

Takeda receives FDA complete response letter for fixed-dose Actos and alogliptin benzoate

FDA accepts for review Bristol-Myers Squibb's BLA for belatacept

FDA issues warning for Myfortic

Array BioPharma reports topline results from phase II ARRY-162 trial

Dilafor reports phase II tafoxiparin results in preventing protracted labor

Acura and King Pharmaceuticals provide update on Acurox NDA

Shionogi reports results from first quarter 2009, ended June 30

Japanese launch for GSK's dutasteride for benign prostatic hyperplasia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...